G Gardani
Impact in
- Otorhinolaryngology top 0.5%
- Head and Neck Cancer Studies
- Oncology top 5%
Papers in
- Oncology 32
- Cancer Treatment and Pharmacology 13
- Cancer Diagnosis and Treatment 6
-
- Advanced Breast Cancer Therapies 5
- Co-authors
- Paolo Lissoni (27 shared papers)C Chenal (2 shared papers)Jean-Claude Horiot (2 shared papers)W. Van den Bogaert (2 shared papers)R. Le Fur (2 shared papers)M. Bolla (2 shared papers)M. De Pauw (2 shared papers)T. Nguyen (2 shared papers)
In The Last Decade
G Gardani
66 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Otorhinolaryngology 561
- Oncology 660
- Radiation 180
- Endocrine and Autonomic Systems 136
- Pulmonary and Respiratory Medicine 499
Countries citing papers authored by G Gardani
This map shows the geographic impact of G Gardani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Gardani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Gardani more than expected).
Fields of papers citing papers by G Gardani
This network shows the impact of papers produced by G Gardani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Gardani. The network helps show where G Gardani may publish in the future.
Co-authors
The 25 scholars most cited alongside G Gardani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy Hit paper breakdown → | 1992 | 496 |
| 2 | 2009 | 127 | |
| 3 | 2004 | 95 | |
| 4 | Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulating dendritic cells, IL-12 and endothelin-1. | 2002 | 88 |
| 5 | Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations. | 2003 | 87 |
| 6 | Effect of bicalutamide therapy on prolactin response to L-dopa in metastatic prostate cancer patients. | 2002 | 72 |
| 7 | 2012 | 49 | |
| 8 | 1990 | 48 | |
| 9 | Radiotherapy-induced lymphocytopenia: changes in total lymphocyte count and in lymphocyte subpopulations under pelvic irradiation in gynecologic neoplasms. | 2006 | 42 |
| 10 | 2000 | 41 | |
| 11 | 2007 | 35 | |
| 12 | 1984 | 34 | |
| 13 | 2009 | 31 | |
| 14 | 2003 | 30 | |
| 15 | 1997 | 27 | |
| 16 | 2013 | 27 | |
| 17 | A progress study of 100 cancer patients treated by acupressure for chemotherapy-induced vomiting after failure with the pharmacological approach. | 2007 | 24 |
| 18 | 2003 | 23 | |
| 19 | A phase II study of chemoneuroimmunotherapy with platinum, subcutaneous low-dose interleukin-2 and the pineal neurohormone melatonin (P.I.M.) as a second-line therapy in metastatic melanoma patients progressing on dacarbazine plus interferon-alpha. | 2003 | 22 |
| 20 | Enhancement of the efficacy of weekly low-dose taxotere by the long acting anti-prolactinemic drug cabergoline in pretreated metastatic breast cancer. | 2005 | 22 |
About G Gardani
G Gardani is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Otorhinolaryngology and Cancer Research, having authored 67 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (13 papers), Head and Neck Cancer Studies (11 papers), Estrogen and related hormone effects (6 papers), Breast Cancer Treatment Studies (6 papers), Cancer Diagnosis and Treatment (6 papers), Cancer, Stress, Anesthesia, and Immune Response (5 papers), Angiogenesis and VEGF in Cancer (5 papers) and Advanced Breast Cancer Therapies (5 papers). The work is most often cited by research in Otorhinolaryngology (561 citations), Oncology (660 citations), Radiation (180 citations), Endocrine and Autonomic Systems (136 citations) and Pulmonary and Respiratory Medicine (499 citations). G Gardani has collaborated with scholars based in Italy, Belgium and France. Frequent co-authors include Paolo Lissoni, C Chenal, Jean-Claude Horiot, W. Van den Bogaert, R. Le Fur, M. Bolla, M. De Pauw, T. Nguyen, M. van Glabbeke and S Schraub. Their work appears in journals such as The International Journal of Biological Markers, Radiotherapy and Oncology, International Journal of Radiation Oncology*Biology*Physics, Journal of Clinical Oncology and European Journal of Nuclear Medicine and Molecular Imaging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.